DR klinika, UAB - financials and debts

Company age: 17 y. 10 mo.

Update

DR klinika - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 458,198 453,891 342,915 617,528 560,277 472,057 445,874 480,900
Profit before tax - - - - - - - -
Net profit 38,768 71,093 61,613 135,225 128,187 63,665 80,980 80,917
Equity 41,953 74,279 135,892 271,118 281,658 121,794 202,774 170,749
Liabilities 82,257 63,830 61,451 71,203 83,884 226,764 59,152 137,593
Non-current assets 26,462 18,505 6,096 26,458 7,691 12,911 11,249 9,137
Current assets 95,754 118,137 190,223 313,628 354,428 332,686 247,080 295,095
Total assets 122,216 136,642 196,319 340,086 362,119 345,597 258,329 304,232
Taxes paid
STI taxes - - - - - 83,874 70,294 81,227
Social insurance contributions - - - - - 24,994 27,348 29,585
Financial indicators
Revenue change y/y +7.8% -0.9% -24.4% +80.1% -9.3% -15.7% -5.5% +7.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 31.7% 52.0% 31.4% 39.8% 35.4% 18.4% 31.3% 26.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 92.4% 95.7% 45.3% 49.9% 45.5% 52.3% 39.9% 47.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.5% 15.7% 18.0% 21.9% 22.9% 13.5% 18.2% 16.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 2.0 0.9 0.5 0.3 0.3 1.9 0.3 0.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 31,967 38,357 36,096 88,218 80,040 67,437 61,500 62,052

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

DR klinika - Social security debts

From To Debt, €
2024-12-22 2024-12-22 0.10
2024-12-17 2024-12-20 0.10
2024-11-18 2024-12-10 0.10
2024-10-16 2024-11-10 0.10
2024-07-16 2024-08-08 0.10
2024-06-18 2024-07-11 0.10
2024-05-16 2024-06-10 0.10
2024-04-08 2024-04-11 0.10
2023-12-18 2023-12-26 6.36
2023-11-21 2023-12-13 6.36
2023-10-25 2023-11-12 0.91
2023-10-17 2023-10-19 120.26
2023-09-18 2023-10-10 120.26
2021-10-18 2021-11-14 0.01
2021-09-16 2021-10-12 0.48

DR klinika - VMI tax arrears

From To Overdue, €
2026-05-28 2026-06-05 0.62
2026-04-30 2026-05-22 0.62
2026-03-29 2026-04-26 0.62
2026-03-19 2026-03-24 0.62
2026-02-28 2026-03-13 0.62
2026-01-29 2026-02-21 0.62
2026-01-01 2026-01-24 0.62
2025-12-18 2025-12-29 0.62
2025-11-28 2025-12-15 0.62
2025-10-04 2025-11-25 0.62
2025-09-28 2025-09-29 1100.75
2025-05-29 2025-06-11 0.01
2025-04-24 2025-05-24 0.01
2025-02-28 2025-04-23 0.06

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
DR klinika, UAB (code 302248912) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €480.9K and net profit of €80.9K, which corresponds to a profit margin of 16.8%. Revenue increased by 7.9% year on year and by 1.9% over two years, indicating a moderate recovery after the 2024 decline. Profitability remained solid across the period: net profit rose from €63.7K in 2023 to €81.0K in 2024 and was broadly stable at €80.9K in 2025. The balance sheet also changed materially. Total assets increased to €304.2K in 2025 from €258.3K in 2024, while equity declined to €170.7K from €202.8K and liabilities rose to €137.6K from €59.2K. The equity ratio was 56.1% and debt-to-equity stood at 0.81, suggesting a still moderate leverage profile. Asset turnover was 1.58x, ROE 47.4% and ROA 26.6%. Revenue per employee was €68.7K and profit per employee €11.6K.